Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment

A case of solitary bone metastasis from breast cancer, where MRI assessment of treatment response was inaccurate and whole-body fluorodeoxyglucose ( 18 FDG) positron emission tomography with computed tomography (PET-CT) proved more reliable and objective, is presented.